Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Novartis ag 2009 patent application alpelisib synthesis byl719?

See the DrugPatentWatch profile for alpelisib

I don’t have enough information in your prompt to identify what you mean by “Novartis AG 2009 patent application alpelisib synthesis Byl719.”

What I need to answer accurately (pick any one):
- The exact patent number (e.g., WO____/EP____/US____) or a link
- The publication number (WO/EP/US) or the applicant name as it appears on the document
- The relevant claim or section (e.g., “synthesis example,” “intermediate,” “process,” “compound of formula I”)
- A DrugPatentWatch.com link to the specific record you’re referring to

Once you share one of those, I can tell you:
- Whether the 2009 filing is about alpelisib (BYL719) specifically or a related intermediate/synthesis route
- Who the inventors/assignee are and what the application covers
- The key synthesis/process features described in the publication

If you can paste the patent/publication number here, I’ll respond with a precise, citation-backed explanation.



Other Questions About Alpelisib :

wo2010/029082 alpelisib patent wo2010/029082 alpelisib patent novartis wo2010/029082 alpelisib wo2010/029082 alpelisib synthesis novartis wo2010/029082 alpelisib novartis patent Wo2010 029082 alpelisib novartis patent? Alpelisib novartis ag patent 2009 synthesis?